SERPASIL-ESIDRIX #1
LOE ApproachingNDAORALTABLET
Approved
May 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SERPASIL-ESIDRIX #1 is a combination oral tablet approved in 1959 containing reserpine and hydrochlorothiazide, used for hypertension management. This fixed-dose combination represents a legacy antihypertensive approach combining a rauwolfia alkaloid with a thiazide diuretic. The drug's mechanism involves sympathetic nervous system suppression and sodium/water excretion.
LOE Approaching
This product is in late-stage lifecycle with minimal active commercial investment; career growth opportunities are limited as the brand transitions toward end-of-life management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SERPASIL-ESIDRIX #1 offers minimal career advancement; the product is in end-of-life stage with zero linked job opportunities and declining prescriber engagement. This role is suitable only for professionals focused on legacy portfolio management or regulatory compliance rather than innovation or growth.
Medical Science Liaison (legacy support)Regulatory Affairs (compliance/maintenance)
Worked on SERPASIL-ESIDRIX #1 at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.